Selection of blockbuster announcements

1. Shanghai Fosun Pharmaceutical (02196): Aquilunce injection has been incorporated into the breakthrough therapeutic drug program.

Shanghai Fosun Pharmaceutical (600196) announced that the company's investment in Fosun Kate's Aquilunce injection (trade name: Yikaida ®) for the treatment of recurrent or refractory inert non-Hodgkin's lymphoma (r iNHL) after second-line or more systematic treatment has been included in the breakthrough drug program. At present, in addition to Yikaida ®, there are no other CAR-T cell therapy products approved to market in China. The indication for the product to be included in the breakthrough therapeutic drug program needs to be approved before it can be commercialized in China.

BeiGene, Ltd. (06160): China's State Drug Administration approved Kaiser ®(datuximab β) for the treatment of patients with high-risk neuroblastoma.

BeiGene, Ltd. (06160) issued an announcement, BeiGene, Ltd. and EUSA Pharma jointly announced on August 17, 2021 (EDT) that China's State Drug Administration (NMPA) has approved Kaiser ®(datuximab β) for the treatment of high-risk neuroblastoma patients aged 12 months and older, who have previously achieved at least partial remission after induction chemotherapy, followed by myeloablative therapy and stem cell transplantation. It can also be used in patients with recurrent or refractory neuroblastoma with or without residual lesions. Kaiser ®is a targeted immunotherapy that has been approved by the European Drug Administration (EMA).

3. The net profit of Luoyang Glass (01108) in the first half of the year reached 198 million yuan, an increase of 1126.73% over the same period last year.

Luoyang Glass (01108) announced interim results. For the six months ended June 30, 2021, the company's operating income was 1.595 billion yuan, an increase of 66.52% over the same period last year. The net profit belonging to shareholders of listed companies was 198 million yuan, up 1126.73% from the same period last year. The net profit after deducting non-recurring profits and losses belonging to shareholders of listed companies was 186 million yuan, an increase of 2521.22% over the same period last year, and basic earnings per share was 0.3611 yuan.

4. Shanghai Electric (02727) expects to change from profit to loss of 4.79 billion to 4.99 billion yuan in the medium term.

Shanghai Electric (02727) announced an expected loss of 4.79 billion to 4.99 billion yuan (RMB) from January 1, 2021 to June 30, 2021. It made a profit of 1.522 billion yuan in the same period last year. The announcement said that the loss in the first half of the year was mainly caused by large impairment losses in accounts receivable and inventory provision of the company's holding subsidiary, Shanghai Electric Communication Company.

5. Shengjing Bank (02066) was awarded a subsidiary of Shenyang SASAC to increase the holding of domestic capital shares and optimize and adjust the ownership structure.

Shengjing Bank issued an announcement, Shengjing Bank (02066) recently received documents related to the transfer of shares of Northeast Pharmaceutical Group Co., Ltd., a subsidiary of Shenyang State-owned assets Supervision and Administration Commission (hereinafter referred to as Shenyang SASAC) and Shenyang Shengjing Financial Control Investment Group Co., Ltd. (hereinafter referred to as Shengjing Financial Control) and Evergrande Group (Nanchang) Co., Ltd. (hereinafter referred to as Evergrande Nanchang). Dongyao Group and Shengjing Financial Control were transferred to about 138 million domestic shares and 28.8333 million domestic shares held by Shengjing Bank in Nanchang at 6 yuan per share, accounting for 1.57% and 0.33% of Shengjing Bank's total issued shares, respectively.

6. Hengteng Network (00136) is expected to record a net profit of about 110 million-130 million yuan in the first half of the year.

Hengteng Network (00136) announced that it is expected to record a net loss in the first half of 2021, mainly due to warrants issued in early 2021 for the acquisition of Virtual Cinema Entertainment Limited. The fair value loss assessment is based on the rise in the company's share price, of which the Group is expected to record a loss of approximately RMB24 to 2.7 billion due to changes in the fair value of the warrants as at 30 June 2021. The company is still working on the evaluation, and the specific amount of provision has yet to be finalized. Excluding the losses arising from the accounting treatment of the acquisition, the group's business is expected to record a net profit of about RMB1.1 to 130 million in the first half of 2021.

Important matters

BeiGene, Ltd. (06160): China's State Drug Administration approved Kaiser ®(Datuximab β) for the treatment of high-risk neuroblastoma patients

Mega Ophthalmology-B (06622): key Phase III Clinical trial (COSMO) of Cyclosporine An Eye Gel reaches the preset main study end point

People's livelihood Education (01569) will actively build a mutually beneficial and win-win new ecology of "Internet +" vocational education.

Jinke Services (09666): application for conversion of not more than 500 million domestic shares into overseas listed shares and listing on the Stock Exchange approved by the Securities and Futures Commission

Zoomlion Heavy Industry Science and Technology (01157) plans to increase capital and shares in Motech China, a wholly-owned subsidiary.

Oukang Visionary Biology-B (01477): a Real World study of OT-502 approved in Boao, Hainan

Shanghai Fosun Pharmaceutical (02196): Fosun Kate's Aguilunce injection has been included in the breakthrough therapeutic drug program.

Shanghai Electric (02727) intends to transfer 80.59% stake in Electric International Trade for 1.957 billion yuan.

Shengjing Bank (02066) was awarded a subsidiary of Shenyang SASAC to increase the holding of domestic capital shares and optimize and adjust the ownership structure.

Financial report data

The medium-term return net profit of Luoyang Glass (01108) increased by 1,126.73% to 198 million yuan compared with the same period last year.

People's livelihood Education (01569) the profit attributable to owners in the first half of the year was 380 million yuan, an increase of 62.4% over the same period last year.

Nestor (01316) increased its adjusted EBITDA by 84.1% to US $213 million in the first half of the year.

Shenzhen Holdings (00604) expects medium-term profit attributable to shareholders to increase by about 300% year-on-year.

GDS Holdings Limited-SW (09698) adjusted EBITDA growth of 41.4% to 896 million yuan in the second quarter

Medium-term profit attributable to shareholders of China Shipping Properties (02669) rose 40.4% year-on-year to HK $393 million per share.

Medium-term net profit of Hong Kong and China Gas (01083) rose 34% to HK $778 million

Profit attributable to shareholders in the medium term of 361 degrees (01361) increased by 32.9% over the same period last year to about 401 million yuan

Medium-term profit attributable to shareholders of China Construction International (03311) increased by 20.8% year-on-year to HK $3.5 billion per share.

Medium-term profit attributable to shareholders of time China Holdings (01233) increased by 6% to 1.629 billion yuan compared with the same period last year.

Juteng International (03336) medium-term net profit of HK $37 million fell by about 83.9% compared with the same period last year.

Roewe International (03358) medium-term net profit of US $35.448 million decreased 0.8% compared with the same period last year.

Langham-SS (01270) first half net profit attributable to shareholders HK $19.9 million

Tianfu (06868) first-half net profit of 159 million yuan increased by 40.9% over the same period last year.

The medium-term distributable income of China Merchants Commercial Housing support (01503) reached 97.6 million yuan compared with 19.1% last year.

Italy International (00585) first-half net profit fell by 92.34% to HK $6.38 million

CGN New Energy (01811) expects medium-term profit attributable to shareholders to increase by about 55% compared with the same period last year.

Lego Group (01622) has a profit increase of not less than 50% in the first half of the year

Zhuzhou CRRC Times Electric (03898) expects to return to his mother with a net profit of 1.15 billion to 1.29 billion yuan in the first nine months.

Hengteng Network (00136) is expected to lose 23-2.6 billion RMB in the first half of the year.

Kaisa Health (00876) made a profit of HK $55 million-HK $65 million in the first half of the year and reversed its losses compared with the same period last year.

Shanghai Electric (02727) expects to change from profit to loss of 4.79 billion to 4.99 billion yuan in the medium term.

Genting Hong Kong (00678) projected medium-term consolidated net loss of no more than US $330 million

Repurchase cancellation

New World Development (00017) spent HK $18.65 million to buy back 500000 shares

CK Hutchison (00001) spent HK $20.3024 million to buy back 350500 shares

Lutheran Glass (00868) spent HK $42.015 million to buy back 1.504 million shares